Guillaume Carmona,Francisco Caballero Gonzalez,Richard Heidebrecht,Robert James Miller,Matthias Alexander Oberli,David Peritt,Jared A. Sewell,Devyn McKinley Smith,Omid Veiseh,Paul Kevin Wotton
申请号：
US16651892
公开号：
US20200263196A1
申请日:
2018.09.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Described herein are cell compositions comprising an active cell (e.g., an engineered active cell, e.g., an engineered RPE cell) or derivatives thereof, as well as compositions, pharmaceutical products, and implantable elements comprising an active cell, and methods of making and using the same. The cells and compositions may express a therapeutic agent useful for the treatment of a disease, disorder, or condition described herein.
